Compile Data Set for Download or QSAR
Report error Found 27 Enz. Inhib. hit(s) with all data for entry = 50038573
TargetCannabinoid receptor 1(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260806(N-(1-(6-(3-chloropyridin-4-yl)-5-(4-(trifluorometh...)
Affinity DataIC50: 0.540nMAssay Description:Inverse agonist at human CB1 receptor expressed in SF9 cells assessed as decrease in GTPgammaS levelMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 1(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM21278(SR141716 | 5-(4-chlorophenyl)-1-(2,4-dichloropheny...)
Affinity DataIC50: 1.35nMAssay Description:Inverse agonist at human CB1 receptor expressed in SF9 cells assessed as decrease in GTPgammaS levelMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 1(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260803(1-(6-(2-chloropyridin-4-yl)-5-(4-(trifluoromethyl)...)
Affinity DataIC50: 3.07nMAssay Description:Inverse agonist at human CB1 receptor expressed in SF9 cells assessed as decrease in GTPgammaS levelMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 1(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260681(4-[6-(3-Chloro-pyridin-4-yl)-5-(4-trifluoromethyl-...)
Affinity DataIC50: 4.20nMAssay Description:Inverse agonist at human CB1 receptor expressed in SF9 cells assessed as decrease in GTPgammaS levelMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 1(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260806(N-(1-(6-(3-chloropyridin-4-yl)-5-(4-(trifluorometh...)
Affinity DataKi:  0.240nMAssay Description:Antagonist activity at human CB1 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 1(Rat)
Neurogen

Curated by ChEMBL
LigandPNGBDBM21278(SR141716 | 5-(4-chlorophenyl)-1-(2,4-dichloropheny...)
Affinity DataKi:  0.310nMAssay Description:Antagonist activity at rat CB1 receptor in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 1(Rat)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260806(N-(1-(6-(3-chloropyridin-4-yl)-5-(4-(trifluorometh...)
Affinity DataKi:  0.410nMAssay Description:Antagonist activity at rat CB1 receptor in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 1(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM21278(SR141716 | 5-(4-chlorophenyl)-1-(2,4-dichloropheny...)
Affinity DataKi:  0.430nMAssay Description:Antagonist activity at human CB1 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 1(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260767(1-(5-(4-chlorophenyl)-6-(2-chloropyridin-4-yl)pyra...)
Affinity DataKi:  0.670nMAssay Description:Antagonist activity at human CB1 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 1(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260805(N-(1-(6-(3-chloropyridin-4-yl)-5-(4-(trifluorometh...)
Affinity DataKi:  0.800nMAssay Description:Antagonist activity at human CB1 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 1(Rat)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260681(4-[6-(3-Chloro-pyridin-4-yl)-5-(4-trifluoromethyl-...)
Affinity DataKi:  0.830nMAssay Description:Antagonist activity at rat CB1 receptor in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 1(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260681(4-[6-(3-Chloro-pyridin-4-yl)-5-(4-trifluoromethyl-...)
Affinity DataKi:  0.830nMAssay Description:Antagonist activity at human CB1 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 1(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260768(1-(6-(2-chloropyridin-4-yl)-5-(4-(trifluoromethyl)...)
Affinity DataKi:  0.870nMAssay Description:Antagonist activity at human CB1 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 1(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260682(1-(5-(4-chlorophenyl)-6-(2,4-dichlorophenyl)pyrazi...)
Affinity DataKi:  0.910nMAssay Description:Antagonist activity at human CB1 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 1(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260803(1-(6-(2-chloropyridin-4-yl)-5-(4-(trifluoromethyl)...)
Affinity DataKi:  1.20nMAssay Description:Antagonist activity at human CB1 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 1(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260718(1-(6-(2-chlorophenyl)-5-(4-chlorophenyl)pyrazin-2-...)
Affinity DataKi:  1.66nMAssay Description:Antagonist activity at human CB1 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 1(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260717(1-(6-(2,4-dichlorophenyl)-5-(4-fluorophenyl)pyrazi...)
Affinity DataKi:  1.75nMAssay Description:Antagonist activity at human CB1 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 1(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260804(N-(1-(6-(3-chloropyridin-4-yl)-5-(4-(trifluorometh...)
Affinity DataKi:  1.97nMAssay Description:Antagonist activity at human CB1 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 1(Rat)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260803(1-(6-(2-chloropyridin-4-yl)-5-(4-(trifluoromethyl)...)
Affinity DataKi:  2.06nMAssay Description:Antagonist activity at rat CB1 receptor in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 1(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260720(1-(5,6-bis(4-ethoxyphenyl)pyrazin-2-yl)-4-(ethylam...)
Affinity DataKi:  2.84nMAssay Description:Antagonist activity at human CB1 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 1(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260766(1-(5-(4-chlorophenyl)-6-(pyridin-4-yl)pyrazin-2-yl...)
Affinity DataKi:  9.81nMAssay Description:Antagonist activity at human CB1 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 1(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260719(1-(6-(2-chlorophenyl)-5-(4-ethoxyphenyl)pyrazin-2-...)
Affinity DataKi:  15.0nMAssay Description:Antagonist activity at human CB1 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 1(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260765(1-(5-(4-chlorophenyl)-6-(4-cyanophenyl)pyrazin-2-y...)
Affinity DataKi:  32.3nMAssay Description:Antagonist activity at human CB1 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM21278(SR141716 | 5-(4-chlorophenyl)-1-(2,4-dichloropheny...)
Affinity DataKi:  815nMAssay Description:Antagonist activity at human CB2 receptor in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260681(4-[6-(3-Chloro-pyridin-4-yl)-5-(4-trifluoromethyl-...)
Affinity DataKi:  1.90E+3nMAssay Description:Antagonist activity at human CB2 receptor in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260806(N-(1-(6-(3-chloropyridin-4-yl)-5-(4-(trifluorometh...)
Affinity DataKi:  4.95E+3nMAssay Description:Antagonist activity at human CB2 receptor in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Neurogen

Curated by ChEMBL
LigandPNGBDBM50260803(1-(6-(2-chloropyridin-4-yl)-5-(4-(trifluoromethyl)...)
Affinity DataKi: >5.00E+4nMAssay Description:Antagonist activity at human CB2 receptor in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS bindingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed